Home > Healthcare > Medical Devices > Therapeutic Devices > Extracorporeal Membrane Oxygenation Market

Extracorporeal Membrane Oxygenation Market Trends

Report ID: GMI2720
Published Date: Apr 2023
Report Format: PDF

Download Free Sample

Extracorporeal Membrane Oxygenation Market Trends

A momentous rise in the prevalence of cardiovascular and respiratory disorders has been observed in past few years in the European region and the trend is projected to continue over the coming years. Increasing number of CVD cases resulted in increasing government initiatives and introduction of various programs in the region in order to increase awareness among people. For instance, the Public Health England (PHE) organization is actively involved in major initiatives to support improvements in CVD prevention and reduction. PHE organization works with local partners and provides information regarding advanced therapies and devices including ECMO devices for treating CVD.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market for ECMO stood at over USD 490 million in 2022 and is expanding consistently at more than 3% CAGR driven by the increasing prevalence of respiratory failure and cardiopulmonary diseases.

Extracorporeal cardiopulmonary resuscitation (ECPR) segment is expected to accumulate over 5% market share by 2032 owing to the increasing incidences of sudden cardiac arrests.

Ppediatric segment garnered over USD 100 million in 2022 driven by the increasing prevalence of several pediatric diseases, such as pneumonia, meconium aspiration syndrome, respiratory distress syndrome (RDS), and congenital diaphragmatic hernia (CDH).

North America amassed over 58% share of ECMO market in 2022 due to the increasing elderly populace and the considerable growth in healthcare expenditure across the region.